Reyde blood glucose testing system
Taiwan·Risk Class 2·Aksotek Company·Registered Apr 14, 2021 – Apr 14, 2026Expired- Analysis ID
- 3338eb1a23c8d74c5b4db1dcf2a8b162
- Manufacturer
- Aksotek Company
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- Aksotek Company
- Intended Use
- It is suitable for in vitro diagnostic use, as a monitoring of blood sugar, it can provide diabetic patients to self-detect fingertip microvascular blood glucose value, or provide professionals to detect venous or arterial whole blood and neonatal microvascular blood glucose value.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1345 Glucose Test System
- Import Information
- QMS/QSD;; 國產
- Registration Date
- Apr 14, 2021
- Expiry Date
- Apr 14, 2026
Top companies providing products similar to "Reyde blood glucose testing system"
Recently registered similar products
Access comprehensive regulatory information for Reyde blood glucose testing system in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 3338eb1a23c8d74c5b4db1dcf2a8b162 and manufactured by Aksotek Company. The authorized representative in Taiwan is Aksotek Company.
This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including Aksotek Company, and 1 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.